Stay updated with breaking news from Quest Monkeypox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency...
On Sept. 7, Quest Diagnostics announced its monkeypox test received emergency use authorization from the FDA for use by authorized labs.
Quest Diagnostics, a leading provider of diagnostic information services, has announced that it has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the company's lab-developed molecular diagnostic test to aid in the diagnosis of infection with the Monkeypox virus.
/PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has received emergency...